Answers are grounded in this paper and cite their sources.
Objective. This study proposes Scout-Dose-TCM for direct, prospective estimation of organ-level and effective doses under tube current modulation (TCM) and compares its performance with two established methods. Approach. Contrast-enhanced chest-abdomen-pelvis CT exams from 130 adults (120 kVp, TCM) were analyzed. Reference organ doses for six organs (lungs, kidneys, liver, pancreas, bladder, spleen) were calculated using Monte Carlo (MC)-GPU and TotalSegmentator. These data trained Scout-Dose-TCM, a deep-learning model that predicts organ-level doses corresponding to discrete cosine transform (DCT) basis functions, enabling real-time estimation for any TCM profile. The model includes a feature-learning module that extracts contextual information from lateral and frontal scouts and scan range, and a dose-learning module that outputs DCT-based dose estimates. The loss function incorporated the DCT formulation, ensuring accurate predictions across variable TCM patterns. For comparison, dose estimation was performed following AAPM Task Group 204 (Global CTDI vol ) and its TCM-adapted and organ-specific version (Organ CTDI vol ). The three evaluated methods were extended to estimate effective dose and compared against the approach in AAPM Report 96, which applies a fixed dose-length product-to-effective-dose conversion factor. Five-fold cross-validation assessed generalizability via mean absolute percentage dose errors and R 2 correlations with MC benchmarks. Main Results. Mean organ-level absolute percentage errors were 13% (Global CTDI vol ), 9% (Organ CTDI vol ), and 7% (Scout-Dose-TCM). The largest discrepancies occurred for the bladder (15%, 13%, and 9%). Scout-Dose-TCM significantly reduced organ-level dose errors versus Global CTDI vol ( p < 1 × 10 −7 ) and improved predictions for liver, bladder, and pancreas versus Organ CTDI vol ( p ⩽ 0.005). It also achieved higher R 2 values and lower effective-dose error (3.01%) than Global (3.87%) and Organ (4.16%) CTDI vol , and the AAPM Task Group 96 method (31%). Significance. Scout-Dose-TCM outperformed Global CTDI vol and was comparable to or better than Organ CTDI vol for organ and effective dose estimation without requiring segmentations at inference, demonstrating its clinical potential for prospective dose estimation in CT.
No takes yet. Share an insight, caveat, or question.
Medrano et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: